col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


23 Ergebisse       Seite 1

 [1] 
Springer-Verlag: Chemical Papers
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2026―Jun―13 Integrative analysis of miRNA in COVID-19 using machine learning and in-silico approaches Figen Güzelgül, Erkan Öner, Serap Yalın, Ali Erdinç Yalın, Tuncay Yığıt, Ahmet Cemal Pazarlı, et al. (+2)
2 [GO] 2025―Sep―06 Micropreparative polyacrylamide gel electrophoresis for identification and purification of biomarkers in COVID-19 patients Marziyeh Shahab, Maryam Ijadi Bajestani, Maryam Davardoostmanesh, Hossein Ahmadzadeh
3 [GO] 2025―Aug―01 Biological evaluation and molecular docking of sulfated polysaccharide-derived glucuronic acid from S. platensis as a potential inhibitor of SARS-CoV-2 ORF3a and Envelope (E) proteins Mythili Ravichandran, Mohammed Al-zharani, Fahd A. Nasr, Lina M. Alneghery, J. M. Mohamed, T. T. Ajith Kumar, et al. (+2)
4 [GO] 2025―Mrz―11 Evaluating phytochemicals as SARS-CoV-2 papain-like protease inhibitors: a docking, ADMET and molecular dynamics investigation Padmika Madushanka Wadanambi, Uthpali Mannapperuma, Nimanthi Jayathilaka
5 [GO] 2024―Nov―15 Identification of potential natural product inhibitors against the Mpro enzyme of Covid-19: a computational study Amir Zeb, Bader S. Alotaibi, Muhammad Haroon, Muhammad Sameer, Mubarak A. Alamri, Asaad Khalid, Abdul Wadood
6 [GO] 2024―Mrz―14 5-chloro-3-(2-(2,4-dinitrophenyl) hydrazono)indolin-2-one: synthesis, characterization, biochemical and computational screening against SARS-CoV-2 Felicite Majoumo-Mbe, Neba Abongwa Sangbong, Alain Tadjong Tcho, Cyril T. Namba-Nzanguim, Conrad V. Simoben, Donatus B. Eni, et al. (+7)
7 [GO] 2024―Jan―17 Overview of diagnostic tools and nano-based therapy of SARS-CoV-2 infection Bedanta Bhattacharjee, Damanbhalang Rynjah, Abdul Baquee Ahmed, Arzoo Newar, Sindhuja Sengupta, Sanheeta Chakrabarty, et al. (+2)
8 [GO] 2023―Apr―13 Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs Girish Chandra, Durg Vijay Singh, Gopal Kumar Mahato, Samridhi Patel
9 [GO] 2023―Apr―04 Superior possibilities and upcoming horizons for nanoscience in COVID-19: noteworthy approach for effective diagnostics and management of SARS-CoV-2 outbreak Bedanta Bhattacharjee, Abu Md Ashif Ikbal, Atika Farooqui, Ram Kumar Sahu, Sakina Ruhi, Ayesha Syed, et al. (+3)
10 [GO] 2023―Mrz―30 Correction to: In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19 Zohreh Esam, Malihe Akhavan, Maryam Lotfi, Saeed Pourmand, Ahmadreza Bekhradnia
11 [GO] 2022―Nov―21 An economical and practical procedure of favipiravir synthesis for the treatment of Covid-19 Hacer Karatas, Essam Hamied Ahmed Hanashalshahaby, Unal Catal, Yasar Enes Butun, Elif Kurt, Sahin Gursel, et al. (+2)
12 [GO] 2022―Okt―21 In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19 Zohreh Esam, Malihe Akhavan, Maryam Lotfi, Saeed Pourmand, Ahmadreza Bekhradnia
13 [GO] 2022―Okt―04 Potential antiviral peptides against the nucleoprotein of SARS-CoV-2 Iktedar Mahdi, Humyara Yeasmin, Imtiaz Hossain, Raina Masnoon Badhan, Md. Ackas Ali, Md. Abdul Kaium, et al. (+3)
14 [GO] 2022―Jun―22 Insighting isatin derivatives as potential antiviral agents against NSP3 of COVID-19 Mubashar Ilyas, Shabbir Muhammad, Javed Iqbal, Saniyah Amin, Abdullah G. Al-Sehemi, H. Algarni, et al. (+3)
15 [GO] 2022―Apr―03 In silico approach for the development of novel antiviral compounds based on SARS-COV-2 protease inhibition Vanja P. Ničkčović, Gordana R. Nikolić, Biserka M. Nedeljković, Nebojša Mitić, Snežana Filipović Danić, Jadranka Mitić, et al. (+3)
16 [GO] 2022―Jan―27 Exploring the inhibitory potential of novel bioactive compounds from mangrove actinomycetes against nsp10 the major activator of SARS-CoV-2 replication Shabbir Muhammad, Mahnoor Qaisar, Javed Iqbal, Rasheed Ahmad Khera, Abdullah G. Al-Sehemi, Saleh S. Alarfaji, Muhammad Adnan
17 [GO] 2022―Jan―15 Modelling the DFT structural and reactivity study of feverfew and evaluation of its potential antiviral activity against COVID-19 using molecular docking and MD simulations Shradha Lakhera, Kamal Devlal, Arabinda Ghosh, Papia Chowdhury, Meenakshi Rana
18 [GO] 2021―Okt―19 Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma) variant spike glycoproteins: A computational approach Vidyasrilekha. Yele, Bharat Kumar Reddy. Sanapalli, Afzal Azam. Mohammed
19 [GO] 2021―Okt―18 Structure-based docking, pharmacokinetic evaluation, and molecular dynamics-guided evaluation of traditional formulation against SARS-CoV-2 spike protein receptor bind domain and ACE2 receptor complex B. Harish kumar, Suman Manandhar, Chetan H. Mehta, Usha Y. Nayak, K. Sreedhara Ranganath Pai
20 [GO] 2021―Okt―05 Novel Molecules derived from 3-O-(6-galloylglucoside) inhibit Main Protease of SARS-CoV 2 In Silico Haruna Isiyaku Umar, Adeola Ajayi, Ridwan Opeyemi Bello, Hafsat Olateju Alabere, Afees Akinbode Sanusi, Olamide Olusegun Awolaja, et al. (+2)
21 [GO] 2021―Aug―30 Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets Mahreen Arooj, Ihsan Shehadi, Chahlaa N. Nassab, Ahmed A. Mohamed
22 [GO] 2021―Aug―09 Metal doped fullerene complexes as promising drug delivery materials against COVID-19 Shamsa Bibi, Shafiq Urrehman, Laryeb Khalid, Muhammad Yaseen, Abdul Quyyam Khan, Ran Jia
23 [GO] 2021―Mai―08 An insight into the inhibitory mechanism of phytochemicals and FDA-approved drugs on the ACE2-Spike complex of SARS-CoV-2 using computational methods Vinod Jani, Shruti Koulgi, V. N. Mallikarjunachari Uppuladinne, Uddhavesh Sonavane, Rajendra Joshi
 [1] 

23 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.010 sec